You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 20, May 27, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Medical News & Perspectives
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Conflict of Interest
 •Medical Education
 •Statistics and Research Methods
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

IOM: Increase Policing of Conflicts of Interest

Bridget M. Kuehn

JAMA. 2009;301(20):2083.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In a report released last month, the Institute of Medicine called for a more coordinated effort within the medical profession to police financial conflicts of interest for individuals and institutions (http://www.nap.edu/catalog.php?record_id=12598).

The authors suggest that various organizations band together to establish a standard for the content and format of disclosures of financial conflicts of interest and to standardize the related procedures. For example, the report notes that a computer questionnaire could be created that uses prompts to guide individuals through the process for disclosing their financial conflicts of interest; the collected information could then be automatically reformatted to meet the needs of their academic institution, a medical journal, or other interested party.

Additionally, the report urges the US Congress to pass legislation requiring pharmaceutical, medical device, and biotechnology companies and their foundations to publicly disclose payments to clinicians, researchers, continuing medical education (CME) providers, other . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.